blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2355659

EP2355659 - FUSED HETEROCYCLIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.11.2015
Database last updated on 24.04.2024
Most recent event   Tooltip04.11.2015Application deemed to be withdrawnpublished on 02.12.2015  [2015/49]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[N/P]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2011/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Inventor(s)01 / KUDUK, Scott, D.
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
02 / DI MARCO, Christina, Ng
126 East Lincoln Avenue
Rahway New Jersey 07065-0907 / US
 [2011/33]
Representative(s)Buchan, Gavin MacNicol
Merck & Co., Inc.
European Patent Department
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
[N/P]
Former [2011/33]Buchan, Gavin MacNicol
Merck & Co., Inc. European Patent Department Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Application number, filing date09822434.813.10.2009
[2011/33]
WO2009US60403
Priority number, dateUS20080197096P23.10.2008         Original published format: US 197096 P
[2011/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010047990
Date:29.04.2010
Language:EN
[2010/17]
Type: A1 Application with search report 
No.:EP2355659
Date:17.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 29.04.2010 takes the place of the publication of the European patent application.
[2011/33]
Search report(s)International search report - published on:US29.04.2010
(Supplementary) European search report - dispatched on:EP07.09.2012
ClassificationIPC:A61K31/47, A61K31/4725, C07D401/06, C07D215/233, C07D405/06, C07D409/06, C07D413/06, C07D417/06, A61P25/28
[2012/41]
CPC:
C07D417/06 (EP,US); A61P1/18 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/00 (EP); A61P15/00 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P25/30 (EP); A61P27/06 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/18 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07D215/233 (EP,US);
C07D401/06 (EP,US); C07D405/06 (EP,US); C07D409/06 (EP,US);
C07D413/06 (EP,US) (-)
Former IPC [2011/33]A01N43/42, A61K31/47
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/33]
TitleGerman:FUSIONIERTE HETEROCYCLISCHE M1-REZEPTOR-POSITIVE ALLOSTERISCHE MODULATOREN[2011/33]
English:FUSED HETEROCYCLIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS[2011/33]
French:MODULATEURS DE RÉCEPTEUR M1 ALLOSTÉRIQUES POSITIFS HÉTÉROCYCLIQUES CONDENSÉS[2011/33]
Entry into regional phase23.05.2011National basic fee paid 
23.05.2011Search fee paid 
23.05.2011Designation fee(s) paid 
23.05.2011Examination fee paid 
Examination procedure23.05.2011Examination requested  [2011/33]
22.03.2013Amendment by applicant (claims and/or description)
15.04.2013Despatch of a communication from the examining division (Time limit: M06)
15.10.2013Reply to a communication from the examining division
02.01.2014Despatch of a communication from the examining division (Time limit: M06)
20.06.2014Reply to a communication from the examining division
23.12.2014Despatch of a communication from the examining division (Time limit: M06)
05.05.2015Application deemed to be withdrawn, date of legal effect  [2015/49]
29.07.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/49]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.04.2013
Fees paidRenewal fee
10.10.2011Renewal fee patent year 03
05.10.2012Renewal fee patent year 04
07.10.2013Renewal fee patent year 05
07.10.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2007067489  (MERCK & CO INC [US], et al) [X] 1-15 * claim 31; compound 79 *;
 [X]US2002099208  (YU KUO-LONG [US], et al) [X] 1,5,7,8,12,14 * compounds 179,180,181 *
International search[Y]US7355047  (JOHNSTONE TIMOTHY B C [US], et al);
 [Y]US7217724  (UENO YOSHIHIDE [JP], et al)
by applicantWO2007067489
 WO2004073639
    - EGLEN ET AL., TRENDS IN PHARMACOLOGICAL SCIENCES, (2001), vol. 22, no. 8, pages 409 - 414
    - FISHER, JPN J PHARMACOL, (2000), vol. 84, pages 101 - 112
    - SPALDING ET AL., MOL PHARMACOL, (2002), vol. 61, no. 6, pages 1297 - 1302
    - S. LAZARENO ET AL., MOL PHARMACOL, (2002), vol. 62, no. 6, pages 1491 - 1505
    - S. LAZARENO ET AL., MOL PHARMACOL, (2000), vol. 58, pages 194 - 207
    - PHARMACOL THER, (1993), vol. 58, pages 319 - 379
    - EUR J PHARMACOL, (1996), vol. 295, pages 93 - 102
    - MOL PHARMACOL, (2002), vol. 61, pages 1297 - 1302
    - BIRDSALL ET AL., LIFE SCIENCES, (2001), vol. 68, pages 2517 - 2524
    - CHRISTOPOULOS, NATURE REVIEWS: DRUG DISCOVERY, (2002), vol. 1, pages 198 - 210
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.